Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

UBS raises Informa target to GBP 9.47, maintains buy rating

EditorBrando Bricchi
Published 11/03/2024, 18:54
Updated 11/03/2024, 18:54
© Reuters.

On Monday, UBS increased its price target on Informa Plc (INF:LN) (OTC: IFJPY) shares to GBP 9.47, up from GBP 9.33, while keeping a Buy rating on the stock. The firm identifies Informa as a top pick for the year, highlighting four key areas where the company could outperform expectations and see its valuation rise.

Informa has set a revenue growth target post-2024 of over 5%, a figure UBS believes could be exceeded due to untapped pricing potential in Informa's events sector. Additionally, while Informa's guidance suggests margins will hold steady at around 30%, UBS predicts that higher growth rates could improve operating leverage, thus increasing margins.

The analyst also points to the valuation of TechTarget (NASDAQ:TTGT), a company covered by UBS's SMID team. They have recently set a valuation of $45 per share for TechTarget, which is significantly higher than its current share price of $32. This valuation could represent an additional 40p per share for Informa investors in an optimistic scenario.

Regarding leverage, UBS's base case assumes that Informa will have zero net debt by 2028. However, if the company were to maintain leverage at 1.5 times consolidated EBITDA, at the lower end of their new guidance, and proceed with share buybacks, this could translate to a value of about 20% of Informa's current market capitalization.

Informa's current trading valuation stands at a 13x 2025E PE ratio, or a 7% estimated free cash flow yield, which UBS finds attractive. This assessment underscores UBS's positive outlook on Informa's stock performance potential for the upcoming period.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.